Africa Excluded From Ebola Experimental Drug! While American & Spanish Get Treated!

How come Africa is been excluded for the Ebola experimental drugs? It should be noted that Africa has the highest casualties from the virus.

Americans and recently a Spanish priest are undergoing treatment with the Ebola experimental drug...

The act of excluding Africa from this Ebola experimental drug is somewhat unfair and shows a sign of discrimination.
Additionally, not providing Ebola experimental drugs to Africa at this point in time would lead to a spread of the virus and ultimately results to huge casualties (death) within the African continent... 

This is really sad and inhuman, and this is a call to the international communities, non-governmental organisations including, World Health Organisation, Amnesty international to intervene so that Ebola experimental drug can be brought to Africa to avoid calamity.

Read below article: 

A Spanish priest infected with Ebola is set to be treated with an experimental drug that has been used on two Americans infected with the deadly virus.

Spain’s Health Ministry said in a statement released late on Saturday that the drug called ZMapp arrived at Madrid’s La Paz-Carlos III hospital where Miguel Pajares, 75, is being treated.

Spain’s drug safety agency permitted the “exceptional importation” of ZMapp under a law that allows “the use of non-authorized medications in case ... a patient’s life is in danger and ... [he/she] can’t be treated satisfactorily with an authorized medication,” the statement said.

The priest was one of three people who tested positive for Ebola at a hospital in the Liberian capital Monrovia where he worked.

On Thursday, a medically equipped Spanish airforce plane brought him back to Spain for treatment.

There is currently no known cure for Ebola, a form of hemorrhagic fever whose symptoms are diarrhea, vomiting and bleeding.

The virus spreads through direct contact with infected blood, feces or sweat. It can also be spread through sexual contact or the unprotected handling of contaminated corpses.

Two Americans infected with Ebola while treating patients in Liberia have shown signs of improvement since receiving Zmapp in the US. However, health officials say it is too early to tell if the drug has been effective.

ZMapp, which is a drug made by private US company Mapp Pharmaceuticals, is still in an extremely early phase of development and had only been tested previously on monkeys.

The World Health Organization has said the clinical trials of vaccines for the Ebola virus would begin soon and the medical protections would become available by early 2015.

Ebola remains one of the world’s most virulent diseases, which kills between 25 to 90 percent of those who get infected by it.

This is while, the deadly virus has so far killed some 1,000 people in West Africa. 

CULLED